Skip to main content
Bigfoot Biomedical announces acquisition of connected insulin pen tech maker

Patients Pending, along with its Timesulin connected insulin pen technology, have been acquired by artificial pancreas developer Bigfoot Biomedical for undisclosed terms. As part of the acquisition, John Sjolund, who founded Patients Pending, will join Bigfoot Biomedical.

Full Story: